Pilot Trial of Cognitive and Behavioral Treatment of Compulsive Hoarding Compared to Wait List Control

January 16, 2020 updated by: Boston University Charles River Campus

Cognitive and Behavioral Treatment of Compulsive Hoarding

This study developed and tested a specialized cognitive and behavioral treatment for the symptoms of hoarding disorder, including excessive acquiring, difficulty discarding items, and extensive clutter in the home.

Study Overview

Status

Completed

Detailed Description

Compulsive hoarding is characterized by excessive acquisition of possessions, difficulty discarding possessions, and excessive clutter. This condition is resistant to standard pharmacological and psychotherapeutic interventions that have proven effective in treating other obsessive compulsive spectrum disorders. This study aimed to determine the effectiveness of a specialized cognitive behavioral therapy (CBT) designed for treating hoarding symptoms.

This study consists of three phases. In Phase 1, pilot data from previous studies were examined to develop an intervention suitable for use in a waitlist trial. In Phase 2, pilot study information were used to develop and test a treatment manual for compulsive hoarding. During this phase, treatment was applied flexibly to allow for variations in treatment duration and choice of techniques. During Phase 3, participants were randomly assigned to 26 weekly sessions of CBT or to a 12-week wait-list control, followed by active treatment for a fixed duration of 26 sessions. Therapist adherence and competence were assessed through audiotaped therapy sessions.

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Connecticut
      • Hartford, Connecticut, United States, 06106
        • Hartford Hospital, Institute of Living
    • Massachusetts
      • Boston, Massachusetts, United States, 02215
        • BostonUCRC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

  • Display at least moderately severe hoarding symptoms
  • Must live within 45 minutes of Boston, MA or Hartford, CT

Exclusion criteria:

  • Ten or more sessions of cognitive behavior therapy for hoarding
  • Concurrent psychotherapy or medications
  • Suicidal, psychotic, or other psychiatric symptoms requiring hospitalization
  • Compulsive buying symptoms that are part of a manic phase of bipolar disorder
  • Mental retardation, dementia, brain damage, or other cognitive dysfunction that would interfere with the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: cognitive behavior therapy for hoarding disorder
Cognitive behavior therapy included 26 sessions of motivational enhancements; skills training for sorting, organizing and problem solving; direct practice not acquiring new items and discarding possessions to remove clutter and organize possessions; cognitive therapy to evaluate beliefs about possessions; and relapse prevention skills.
NO_INTERVENTION: Wait list control
Participants waited to receive treatment for 12 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Saving Inventory-Revised
Time Frame: change from baseline to week 12; change from baseline to week 26
Self-report questionnaire of hoarding severity; total score range = 0 to 92; higher values indicate more symptoms
change from baseline to week 12; change from baseline to week 26

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hoarding Rating Scale
Time Frame: change from baseline to week 12; change from baseline to week 26
Interviewer measure with 5 questions to assess hoarding severity; total score range = 0 to 40; higher values indicate more symptoms
change from baseline to week 12; change from baseline to week 26

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gail Steketee, Boston University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 1, 2003

Primary Completion (ACTUAL)

December 1, 2006

Study Completion (ACTUAL)

July 9, 2008

Study Registration Dates

First Submitted

November 19, 2003

First Submitted That Met QC Criteria

November 20, 2003

First Posted (ESTIMATE)

November 21, 2003

Study Record Updates

Last Update Posted (ACTUAL)

January 21, 2020

Last Update Submitted That Met QC Criteria

January 16, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • R21MH068539 (NIH)
  • DATR A2-AIA

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

De-identified data have been shared with investigators working on hoarding relevant projects such as assessment of hoarding and meta-analyses of treatment outcome for hoarding disorder. Sharing of de-identified data will be considered upon request.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obsessive-Compulsive Disorder

Clinical Trials on Cognitive Behavioral Treatment

3
Subscribe